Details of Bacterial Vaccine
This bacterial vaccine card gives comprehensive information about each vaccine.
| Detailed Information | |
|---|---|
| ID | 1178 |
| Name of the vaccine | SA4AG |
| Microbe | Bacteria |
| Disease name | Methicillin-Resistant Staphylococcus aureus (MRSA) |
| Name of bacteria | Staphylococcus aureus |
| Type of vaccine | Polysaccharide |
| Nucleic acid content | Circular DNA |
| Age | 18 to 85 years |
| Description of the vaccine | S. aureus 4-antigen vaccine (SA4Ag). |
| Name of the manufacturer | Pfizer |
| Name of the manufacturing country | Austria, Bulgaria, Canada, France, Germany, Hungary, Japan, Spain, Sweden, United Kingdom, United States |
| Year of manufacture | 2019 |
| Clinical Phase status | Clinical - Terminated |
| Bacterial strain | Gram-positive bacteria. |
| Efficacy | NA |
| Vaccine formulation | Reconstituted in 0.5mL water for injection. |
| Dosage | Single dose. |
| Mechanism of action | Targets S. aureus virulence factors. |
| Route of administration | Intramuscular |
| Indications | Prevents postoperative Staphylococcus aureus infections. |
| Export | NA |
| Approval | NA |
| Adjuvant | NA |
| Repurposing | NA |
| Side effects of vaccine | NA |
| Post vaccination | NA |
| Dose type | Single dose |
| Interspecies transfer | NA |
| PubMed identifier | 27916408 |
| Clinical trial number | NCT02388165 |
| Reference | NA |
| Other name | NA |
| Additional Links | NA |